20 participants
JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-20
- Start Date:
- 2026-07-13
- Completion:
- 2026-11-13
Conditions
- NSCLC Harboring EGFR Mutations
Interventions
- DRUG
No Results Yet